Fresenius SE & Co. KGaA (FSNUF)
54.35
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Fresenius EPS Diluted (Quarterly) : 0.9036 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.9036 |
| December 31, 2025 | 0.746 |
| September 30, 2025 | 0.7138 |
| June 30, 2025 | 0.6641 |
| March 31, 2025 | 0.4279 |
| December 31, 2024 | 0.4545 |
| September 30, 2024 | 0.6358 |
| June 30, 2024 | -0.713 |
| March 31, 2024 | 0.5357 |
| December 31, 2023 | -1.172 |
| September 30, 2023 | -0.7922 |
| June 30, 2023 | -0.2264 |
| March 31, 2023 | 0.6658 |
| December 31, 2022 | 0.4662 |
| September 30, 2022 | 0.5799 |
| June 30, 2022 | 0.7278 |
| March 31, 2022 | 0.8381 |
| December 31, 2021 | 1.021 |
| September 30, 2021 | 0.8717 |
| June 30, 2021 | 1.013 |
| March 31, 2021 | 0.9396 |
| December 31, 2020 | 0.8703 |
| September 30, 2020 | 0.90 |
| June 30, 2020 | 0.8149 |
| March 31, 2020 | 0.9065 |
| Date | Value |
|---|---|
| December 31, 2019 | 1.023 |
| September 30, 2019 | 0.8784 |
| June 30, 2019 | 0.9551 |
| March 31, 2019 | 0.923 |
| December 31, 2018 | 1.054 |
| September 30, 2018 | 0.8723 |
| June 30, 2018 | 1.393 |
| March 31, 2018 | 0.9709 |
| December 31, 2017 | 1.071 |
| September 30, 2017 | 0.834 |
| June 30, 2017 | 0.8921 |
| March 31, 2017 | 0.874 |
| December 31, 2016 | 0.8621 |
| September 30, 2016 | 0.7701 |
| June 30, 2016 | 0.7791 |
| March 31, 2016 | 0.7166 |
| December 31, 2015 | 0.799 |
| September 30, 2015 | 0.7002 |
| June 30, 2015 | 0.6416 |
| March 31, 2015 | 0.6408 |
| December 31, 2014 | 0.6121 |
| September 30, 2014 | 0.6624 |
| June 30, 2014 | 0.7131 |
| March 31, 2014 | 0.612 |
| December 31, 2013 | 0.726 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Fresenius Medical Care AG | 0.2498 |
| Exlites Holdings International, Inc. | -0.0004 |
| Xcelerate, Inc. | 0.00 |
| Merck KGaA | 0.3547 |
| Rafina Innovations, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 520.62M |
| Revenue (Quarterly) | 6.808B |
| Total Expenses (Quarterly) | 6.298B |
| Enterprise Value | 42.74B |
| Gross Profit Margin (Quarterly) | 26.38% |
| Profit Margin (Quarterly) | 7.65% |
| Earnings Yield | 5.57% |
| Operating Earnings Yield | 8.25% |
| Normalized Earnings Yield | 5.570 |